Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Virginia Coleman Drosos, Murali Prahalad

Premium

Assurex Health announced that Virginia Coleman Drosos is the company's new president. Drosos comes to Assurex after 25 years at Procter & Gamble, where she held various positions. Most recently, she was group president for global beauty care at P&G.


Circulating tumor cell diagnostics developer Epic Sciences has appointed Murali Prahalad to be president and CEO.

Prahalad formerly held multiple posts at Life Technologies, and most recently he was VP of corporate strategies at the firm.

Before he joined Life Technologies, he was VP of business development at Sequenom, and he was a consultant for The Advisory Board Company and an analyst at Gemini Consulting in Tokyo.

Filed under

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.